Can I read ETI Impact on CF Hospitalizations & Antibiotics on EtoBox?

ETI Impact on CF Hospitalizations & Antibiotics by mehdi.jafari7471 is a document available to read on EtoBox.

What is ETI Impact on CF Hospitalizations & Antibiotics about?

This study evaluates the impact of elexacaftor/tezacaftor/ivacaftor (ETI) on hospitalization and intravenous (IV) antibiotic use among cystic fibrosis patients. Results indicate a significant reduction in hospital days (86%) and IV antibiotic days (80%) post-ETI initiation, particularly among patients with severe lung disease. These findings suggest that ETI is effective in decreasing the burden of hospitalizations and antibiotic use in cystic fibrosis management.

Author

mehdi.jafari7471

Language

EN